3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
20
Fatigue
16
Neoplasms
8
Depression
6
Pain
5
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Vomiting
2
Sleep Wake Disorders
2
Sleep Initiation and Maintenance Disorders
2
Rectal Neoplasms
2
Polycystic Ovary Syndrome
2
Parasomnias
2
Oligodendroglioma
2
Obesity
2
Nausea
2
Motor Activity
2
Meningioma
2
Medulloblastoma
2
Lymphedema
2
Leukemia
2
Head and Neck Neoplasms
2
Gliosarcoma
2
Glioblastoma
2
Ependymoma
2
Interventions
Bupivacaine
5
Anesthesia, Local
5
Anesthesia, General
5
Morphine
4
Dexmedetomidine
4
Acupuncture Therapy
4
parecoxib
3
Transcutaneous Electric Nerve Stimulation
3
Saline Solution
3
Ropivacaine
3
Radiofrequency Ablation
2
Pregabalin
2
Fentanyl
2
Ethanol
2
Dental Occlusion
2
Control Groups
2
Anesthetics, Local
2
Anesthesia, Spinal
2
Anesthesia, Conduction
2
Analgesics, Opioid
2
loxoprofen
1
engage 8200
1
Yoga
1
Uterine Myomectomy
1
Transcranial Magnetic Stimulation
1
Transcranial Direct Current Stimulation
1
Tramadol
1
Touch
1
Therapeutics
1
Telemedicine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Agnosia
×
Yoga
×
Clear all
NCT05121558
2026-02-06
YCT
Dana-Farber Cancer Institute
Phase NA
Active not recruiting
227 enrolled